Login / Signup
FLOW trial stopped early due to evidence of renal protection with semaglutide.
Felice Gragnano
Vincenzo De Sio
Paolo Calabrò
Published in:
European heart journal. Cardiovascular pharmacotherapy (2023)
Keyphrases
</>
phase iii
study protocol
clinical trial
phase ii